Weave Communications, Inc.
WEAV Healthcare Health Information Services
Weave Communications, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $239.0 million, up 17.0% from fiscal 2024. In the quarter to June 2026, revenue grew 15.5%, EPS grew 54.6%, free cash flow grew 94.3% and total debt rose 4.91%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
Follow WEAV
Weave Communications, Inc. (WEAV) EV/Sales
As of 16 October 2026, Weave Communications, Inc. (WEAV) trades at a EV/Sales of 2.0×. Over the past ten years it has ranged from 0.0× (March 2022) to 5.7× (February 2025); the current reading is higher than 45% of that period. That is below the Health Information Services industry median of 2.6× and below the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 2.1× | (58.50%) |
| FY2024 | 5.2× | 28.22% |
| FY2023 | 4.0× | 200.55% |
| FY2022 | 1.3× | (23.04%) |
| FY2021 | 1.7× | (26.09%) |
| FY2020 | 2.4× | 0.00% |
| FY2019 | 2.4× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 1.6× | 30.80% |
| Mar 2026 | 1.2× | (42.62%) |
| Dec 2025 | 2.1× | 9.09% |
| Sep 2025 | 2.0× | (23.69%) |
| 21 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| MDRX Veradigm Inc. compare | 0.6× |
| EVH Evolent Health, Inc compare | 0.6× |
| PHR Phreesia, Inc. compare | 1.5× |
| WEAV Weave Communications, Inc. | 2.0× |
| HSTM HealthStream, Inc. compare | 2.9× |
| NRC National Research Corporation compare | 3.8× |
| CARL Carlsmed, Inc. compare | 4.6× |
| CTEV Claritev Corporation compare | 5.0× |
| SOPH SOPHiA GENETICS SA compare | 5.1× |
| Health Information Services industry median | 2.6× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)